Dravet Syndrome Recent News
FDA Rejects Regulatory Filing For Zogenix Epilepsy Drug; GW Pharma Moves In Sympathy
Additional Late-Stage Study Confirms Efficacy, Safety Of GW Pharma's Epidiolex
Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study
Why GW Pharma's Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics
Zogenix's Dravet Syndrome Treatment Returns 'Strong'